The burden of drug overdose deaths among correctional populations: implications for interventions

Commentary
by
Fischer, B., Moghimi, E., & Weekes J.

Release Date

2024

Geography

Canada

Language of Resource

English

Full Text Available

Yes

Open Access / OK to Reproduce

Yes

Peer Reviewed

Yes

Objective

This is a commentary on a resent cost–benefit analysis done by Houdroge and colleagues of expanding needle exchange programs across federal prisons in Canada, who conclude that doing so would lead to substantial health care–related savings, particularly in the area of preventing transmissions of infections. 

Findings/Key points

The authors of this article argue that incarceration-exposed individuals in Canada are disproportionately affected by a wide range of chronic diseases, including mental health and substance use disorders. Prison populations are not exempt from the devastating crisis of drug-related overdose deaths that has been unfolding across North America over the last decade. More comprehensive interventions to make substance use in correctional institutions safer, and specifically reduce related risks of acute death, are needed. They discuss substance use–related harm in correctional environments, efforts and measures developed to mitigate it, and how interventions can be expanded to improve the substance use–related health of incarcerated people in Canada.

Keywords

Advocacy
Barriers and enablers
Harm reduction
Illegal drugs
Injecting drugs
Legal system/law enforcement
Overdose
Policy/Regulatory
Wrap-around services